12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage
Marissa Plescia / medcitynews - In a recent letter, Senate Democrats proposed lowering healthcare costs, expanding coverage and cracking down on insurance company practices.The post 12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage appeared first on MedCity News.
AI Summary: A group of Senate Democrats released a package targeting insurance costs and access, proposing steps to lower premiums, expand coverage pathways and increase oversight of insurers. The agenda signals a coordinated legislative push to tackle affordability and industry practices, setting the stage for heated negotiations with stakeholders who enjoy the current status quo.
- Medicaid enrollment threatened by work requirements and redeterminations (5)
- Other health policy, market and access stories (9)
- PBMs, insulin pricing face bipartisan and regulatory pressure (6)
- Senate Democrats push reforms to curb insurer power (4)
- All Other Stories
Medicaid enrollment threatened by work requirements and redeterminations
Other health policy, market and access stories
PBMs, insulin pricing face bipartisan and regulatory pressure
Senate Democrats push reforms to curb insurer power
All Other Stories
High Cancer Burden Shifted From Urban to Rural Areas and Gap Widening
cancer - Two American Cancer Society studies highlight increase in cancer burden in rural areas
AI Summary: Recent analyses show the colorectal cancer burden has moved increasingly from urban centers to rural areas, widening disparities. Researchers attribute the shift to screening shortfalls, limited access to specialty care and socioeconomic barriers, and call for targeted screening, resource reallocation and tailored prevention efforts as rural populations face rising incidence and poorer outcomes.
- Clinical trials and treatment advances (6)
- Early-onset, prevention, and genetics (5)
- Rural burden and access disparities (8)
- All Other Stories
Clinical trials and treatment advances
Early-onset, prevention, and genetics
Rural burden and access disparities
All Other Stories
Why Providence Wants to Sell Its Health Plan
Katie Adams / medcitynews - Providence announced its intent to sell its health plan, exiting the “payvider” model as rising costs and operational complexity weigh on smaller regional insurers. The move reflects a broader trend of health systems refocusing on core care delivery and e…
AI Summary: Providence Healthcare is actively weighing the sale of its health insurance arm as mounting fiscal pressures force leaders to consider dramatic options. The move would reshape the system’s payer-provider footprint, potentially easing balance‑sheet strain while unnerving patients, employers and regulators who’ll suddenly have a stake in the decision.
Britain rushes to contain deadly meningitis outbreak
medicalxpress - Over 10 people were hospitalized in the UK and students urged to take preventative antibiotics Tuesday as health officials rushed to treat a deadly meningitis outbreak linked to a nightclub.
AI Summary: Health officials in southern England have mounted an urgent response to a fast‑moving meningococcal outbreak tied to student nightlife in Kent, after multiple hospitalizations and at least two deaths. Authorities are offering antibiotics, assessing vaccine policy for teens, and urging vigilance as contact tracing and public health measures try to stop transmission before more young people fall ill.
- Human stories: parents and survivors recount meningitis's devastation (5)
- Live from Kent: explosive student meningitis outbreak and response (14)
- Other coverage: science, trials and unrelated tech pieces (9)
- Policy spotlight: why teens missed MenB vaccine, debate intensifies (6)
- All Other Stories
Human stories: parents and survivors recount meningitis's devastation
Live from Kent: explosive student meningitis outbreak and response
Other coverage: science, trials and unrelated tech pieces
Policy spotlight: why teens missed MenB vaccine, debate intensifies
All Other Stories
Bluesky Mentions: @justinhendrix.bsky.social
Federal court blocks RFK Jr.’s moves to upend US vaccine policy
Delilah Alvarado / healthcaredive - The ruling, related to a lawsuit from several major medical organizations, said that HHS ignored established protocols when altering the childhood immunization schedule and overhauling a key CDC panel.
AI Summary: A federal judge blocked actions by an HHS official seeking to alter longstanding childhood vaccine policies, ruling the department failed to follow established procedures. The decision reaffirms agency protocol for vaccine recommendations and curbs abrupt unilateral policy shifts, restoring a measure of regulatory due process.
- Courts curb HHS unilateral actions across vaccines and gender care (6)
- HHS leadership chaos and White House reining in RFK Jr. (3)
- States push back, setting their own vaccine policies (1)
- All Other Stories
Courts curb HHS unilateral actions across vaccines and gender care
HHS leadership chaos and White House reining in RFK Jr.
States push back, setting their own vaccine policies
All Other Stories
New EPA rule could loosen limits on medical device sterilization gas emissions
medicalxpress - The U.S. Environmental Protection Agency (EPA) is proposing to loosen limits on emissions of ethylene oxide, a gas used to sterilize many medical devices that is also linked to cancer.
AI Summary: The Environmental Protection Agency proposed easing limits on ethylene oxide — the gas hospitals use to sterilize medical devices — arguing the change protects the medical supply chain. Public‑health experts and community advocates warn long‑term exposure raises cancer risks and say rolling back 2024 safeguards could shift the burden onto nearby residents.
Officials examine deaths after plasma donations in Winnipeg
medicalxpress - Canadian health officials are investigating the deaths of two people who donated plasma at private clinics in Winnipeg, Manitoba.
AI Summary: Health officials are investigating the deaths of two people who recently donated plasma at for‑profit clinics in Winnipeg, prompting scrutiny of donation frequency, screening practices and clinic oversight. Regulators are reviewing protocols and collecting evidence as public health teams work to determine whether systemic safety failures or procedural lapses contributed to the fatalities.
FDA Drug Approval Marks a First for a Disease — But It’s Not Autism
Frank Vinluan / medcitynews - Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence.The post …
AI Summary: The FDA has granted traditional approval to leucovorin for cerebral folate deficiency, formalizing a decades‑old generic’s role in a rare metabolic disorder. The decision comes amid earlier agency notes that evidence for autism benefit was weak and debate over expanding use without fresh trial data — cue the policy hot takes.
Fitch upgrades UCHealth’s rating to ‘AA+’
Andrew Cass / beckershospitalreview - Aurora, Colo.-based UCHealth’s credit rating was upgraded to “AA+” from “AA” by Fitch. The upgrade reflects the health system’s very strong financial profile, benefiting from its market position in a growing service area and a long track record of robust …
AI Summary: A large NHS evaluation found that an AI system can detect more invasive breast cancers than traditional reading alone, boosting detection by roughly 10%. The technology matched or rivaled radiologists in a major screening dataset, prompting debate about integration, workflow changes, and careful real-world rollout rather than unleashing bots in mammography rooms immediately.
- Mixed trial findings: AI triage not always noninferior. (1)
- NHS trial: AI boosts breast cancer detection by ~10%. (2)
- OTHER: AI in broader cardiac, hematology, imaging, and finance news. (4)
- Researchers and conferences push AI discussion in breast imaging. (2)
- All Other Stories
Mixed trial findings: AI triage not always noninferior.
NHS trial: AI boosts breast cancer detection by ~10%.
OTHER: AI in broader cardiac, hematology, imaging, and finance news.
Researchers and conferences push AI discussion in breast imaging.
All Other Stories
Measles outbreaks could fuel rise in fatal complication, physicians warn
Mackenzie Bean / beckershospitalreview - As measles continues spreading across the U.S. at a pace not seen in decades, physicians are warning about a rare but often fatal neurological complication that can emerge years after initial infection, KFF Health News reported March 13. Subacute sclerosi…
AI Summary: Measles is resurging across the United States at levels not seen in decades, and clinicians warn this spike could drive an increase in a rare but often fatal neurological complication. Public‑health experts point to falling vaccination coverage and gaps in outbreak control as the drivers, urging renewed immunization efforts and vigilance.
AMA: Physicians' use of AI doubled from 2023 to 2026
fiercehealthcare - A survey fielded earlier this year found 81% of doctors use AI in a professional context, with an average of 2.3 use cases per physician. Respondents were largely bullish on the technology's ability to boost clinical care and work efficiency, but still ha…
AI Summary: An AMA survey finds physicians’ professional use of artificial intelligence roughly doubled from 2023 to 2026, with about 81% of doctors now using AI across clinical and administrative tasks. The rapid uptake spotlights workflow integration but raises immediate questions about oversight, training, and legal liability as adoption outpaces policy.
FDA Transparency Push Expands to Monitoring Safety of Vaccines and Other Regulated Products
Frank Vinluan / medcitynews - The FDA said consolidating safety reporting into a single platform, the Adverse Event Monitoring System (AEMS), will increase transparency and reduce costs. But like the legacy systems it replaces, AEMS reports are unverified so causation and frequency of…
AI Summary: The FDA is consolidating multiple safety reporting systems into a single public Adverse Event Monitoring System to centralize reports for drugs, biologics, vaccines, cosmetics and animal products. The move aims to improve transparency, reduce fragmented reporting, and streamline monitoring — a tidy solution if it works as promised.
Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
fiercehealthcare - Healthcare affordability remains a significant challenge, with a third of respondents to a new Gallup poll saying they had to cut back on daily living expenses to afford care.
AI Summary: A Gallup poll reports one-third of Americans trimmed everyday spending, borrowed money or skipped essentials to pay medical bills. The findings highlight acute affordability pressures that force families to choose between care and basic needs, underscoring systemic gaps in coverage and cost control while policymakers offer the usual sympathetic nod.
Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
fiercehealthcare - Aetna has agreed to pay $117.7 million to settle allegations that it submitted false or inaccurate diagnoses to juice Medicare Advantage payments.
AI Summary: CVS Health (via its Aetna unit) agreed to a roughly $118 million settlement with the DOJ to resolve False Claims Act allegations that inaccurate diagnosis submissions inflated Medicare Advantage payments. The deal closes a chapter on federal scrutiny of coding practices and aims to avoid years more of litigation and bad headlines.
Leapfrog ordered to remove safety grade for 5 Tenet hospitals
fiercehealthcare - A federal judge said a 2024 methodology update that adjusted the weighting of safety measures inputted for nonparticipating hospitals was "deceptive and unfair" under Florida law. Leapfrog plans to appeal, but said it will be making broader changes in rat…
AI Summary: A federal judge ruled that Leapfrog’s safety grades for five Florida hospitals—primarily Tenet-owned facilities—were based on a methodology the court deemed scientifically unsupported and potentially deceptive. The decision requires Leapfrog to take down those grades, raising fresh questions about the design, transparency and legal defensibility of high-profile hospital safety metrics.
White House autism briefing linked to swift shifts in prescribing patterns
medicalxpress - A White House briefing in September 2025 that raised concerns about acetaminophen use during pregnancy and promoted the drug leucovorin as a potential autism treatment was followed by sharp changes in how doctors prescribed those medications nationwide, a…
AI Summary: A White House briefing warning about acetaminophen in pregnancy and promoting alternate therapies led to an immediate, measurable decline in ER acetaminophen orders for pregnant patients. The episode shows how high‑profile public messaging can swiftly reshape clinical behavior — for better or worse — and raises questions about evidence, communication and unintended consequences.
CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance
oncodaily - ALRCaN presents “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS” with Dr. Valentín Ortiz-Maldonado. “Dear friends and colleagues, […]
AI Summary: Bereaved relatives delivered searing final testimonies as the Covid inquiry wound up four years of public hearings, recounting loved ones who died alone and demanding answers. Chair Baroness Heather Hallett defended the process and its roughly £200 million price tag as necessary to finish the work, despite public frustration and political scrutiny.
Telehealth growth hasn’t increased rural behavioral healthcare access: Study
Giles Bruce / beckershospitalreview - The rise in telemedicine over the past several years hasn’t translated to more behavioral healthcare access in rural areas, according to a March 5 study in JAMA Network Open. Researchers from Boston-based Harvard Medical School and Providence, R.I.-based …
AI Summary: A new study finds the rapid expansion of telemedicine did not meaningfully improve access to behavioral health services in rural areas. Persistent barriers—workforce shortages, broadband gaps, and reimbursement limits—keep telehealth from being the miracle fix some hoped for. Turns out, high-speed internet isn’t a therapist.
New FDA bonus pilot to address 'workforce challenges'
Max Bayer / endpoints - A new bonus pilot program meant to reward fast-working FDA reviewers will be funded in part by money from industry user fees, the first details on how Commissioner Marty Makary plans to finance the incentive ...
AI Summary: The FDA has introduced a pilot program offering performance bonuses to expedite regulatory reviews, aiming to tackle reviewer workload and improve timeliness. Funded partly by industry user fees, the initiative seeks to reward faster, high‑quality reviews while balancing independence and efficiency—proof that carrots sometimes replace the endless stick of overtime.
Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC
Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.
AI Summary: Federal regulators and two pharmacy benefit managers are reportedly making substantial progress toward resolving an FTC antitrust probe tied to insulin pricing and PBM practices. Negotiations aim to settle allegations without protracted litigation, potentially changing how PBMs operate and how insulin costs are managed for states and patients.